SLU-PP-332oral or injectable SLU-PP-332 is emerging as a significant compound in the realm of scientific research, particularly for its potential to mimic the metabolic benefits of exercise. This synthetic small-molecule, also referred to as PP 332 or SLU PP 332, is a potent and selective pan-agonist of the estrogen receptor-related receptors (ERRs). Its mechanism of action centers on activating these receptors, primarily ERRα, with an EC50 of 98 nM, to influence cellular processes related to energy regulation and metabolic function.
Research into SLU-PP-332 highlights its capacity to act as “exercise in a pill,” a moniker earned by its ability to replicate key outcomes of physical activity at a cellular level. Studies, including those published in peer-reviewed journals like PMC, demonstrate that SLU-PP-332 administration in preclinical models, such as mice, can lead to increased energy expenditure and enhanced fatty acid oxidation. This suggests a profound impact on fat metabolism and a potential avenue for supporting metabolic health.
The science behind SLU-PP-332 involves its interaction with Estrogen-Related Receptors (ERRs).作者:H Nasri·2024—For this study, we searched PubMed, Web ofScience,. EBSCO, Scopus ...SLU-PP-332activates estrogen receptor-related orphan receptors ... These are orphan nuclear receptors, meaning they are not directly activated by estrogen but play crucial roles in regulating gene expression related to energy homeostasis and mitochondrial functionSupport Metabolic Health with SLU-PP-322 | Peptides at Elase. By acting as a pan-agonist of the estrogen receptor-related receptors, SLU-PP-332 can modulate these pathways, potentially leading to improved mitochondrial function and a more efficient use of energy by the body.SLU-PP-332 (8112) by Tocris, Part of Bio-Techne
Peptide research has increasingly focused on compounds that can offer therapeutic benefits with novel mechanisms. While SLU-PP-332 is described as a synthetic small molecule, its functional classification often aligns with the broader category of research compounds investigated for their peptide-like effects on cellular metabolism2025年5月13日—SLU-PP-332is a groundbreaking oralpeptidethat activates ERRα to mimic exercise, improve metabolic health, and restore mitochondrial function— .... The peptide nature of its study and application is a key aspect of its scientific explorationSLU-PP-332isa potent and selective pan estrogen related receptor (ERR) agonist(EC 50 values are 98 nM, 230 nM and 430 nM for ERRα, ERRβ and ERRγ respectively.
The implications of SLU-PP-332 extend to various areas of metabolic health. Research indicates its potential to alleviate conditions associated with metabolic syndrome. For instance, studies have shown that SLU-PP-332 administration can lead to significant weight loss in obese mice, with some reporting a tenfold reduction in fat gain compared to untreated counterparts and a 12% reduction in body weight. Notably, these effects are achieved without influencing appetite or food intake, nor do they necessitate increased physical activity, underscoring its unique mechanism.SLU-PP-332is a compound which is a potent but non-selective estrogen-related receptor (ERR) agonist, acting most strongly at ERRα with an EC50 of 98 nM.
Further scientific investigation into SLU-PP-332 explores its role in endurance and muscle activity.SLU-PP-332· 99% High Purity Product · Discreet and Secure Shipping · Certified Products · SLU32 ... By enhancing mitochondrial function, the compound may contribute to improved stamina and cellular energy production. The precise dosage and administration protocols, such as those involving SLU-PP-332 peptide vials or SLU-PP-332 tablets, are subjects of ongoing research and development within the scientific community. Available in high purity, often exceeding 99%, SLU-PP-332 is utilized in laboratory settings for research and development purposes, with CAS# 303760-60-3 being a key identifier.New exercise mimetic drugSLU-PP-332made obese mice gain 10x less fat than untreated mice and lose 12% of their body weight by boosting the animals metabolism.
The scientific literature also touches upon the SLU-PP-332 peptide Sciences reviews, indicating a growing body of work and user experiences being documented. While the compound is primarily a research tool, its promising results in preclinical studies have sparked considerable interest in its potential applications.SLU-PP-332is a pan-ERR agonist, meaning it activates all three Estrogen-Related Receptors (ERRα, ERRβ, ERRγ). These receptors aren't related to estrogen ... The development of SLU-PP-332 represents a significant advancement in understanding and potentially manipulating metabolic pathways, offering a novel approach to addressing metabolic challenges. The compound's ability to mimic exercise, improve metabolic function, and restore mitochondrial health makes it a compelling subject for continued scientific inquiry.
Join the newsletter to receive news, updates, new products and freebies in your inbox.